Literature DB >> 33536258

Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape.

Kevin R McCarthy1,2,3, Linda J Rennick4,2, Sham Nambulli4,2, Lindsey R Robinson-McCarthy5, William G Bain6,7,8, Ghady Haidar9,10, W Paul Duprex1,2.   

Abstract

Zoonotic pandemics, such as that caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), can follow the spillover of animal viruses into highly susceptible human populations. The descendants of these viruses have adapted to the human host and evolved to evade immune pressure. Coronaviruses acquire substitutions more slowly than other RNA viruses. In the spike glycoprotein, we found that recurrent deletions overcome this slow substitution rate. Deletion variants arise in diverse genetic and geographic backgrounds, transmit efficiently, and are present in novel lineages, including those of current global concern. They frequently occupy recurrent deletion regions (RDRs), which map to defined antibody epitopes. Deletions in RDRs confer resistance to neutralizing antibodies. By altering stretches of amino acids, deletions appear to accelerate SARS-CoV-2 antigenic evolution and may, more generally, drive adaptive evolution.
Copyright © 2021 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33536258      PMCID: PMC7971772          DOI: 10.1126/science.abf6950

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  29 in total

1.  Antibodies to a Conserved Influenza Head Interface Epitope Protect by an IgG Subtype-Dependent Mechanism.

Authors:  Akiko Watanabe; Kevin R McCarthy; Masayuki Kuraoka; Aaron G Schmidt; Yu Adachi; Taishi Onodera; Keisuke Tonouchi; Timothy M Caradonna; Goran Bajic; Shengli Song; Charles E McGee; Gregory D Sempowski; Feng Feng; Patricia Urick; Thomas B Kepler; Yoshimasa Takahashi; Stephen C Harrison; Garnett Kelsoe
Journal:  Cell       Date:  2019-05-16       Impact factor: 41.582

2.  Discovery of an RNA virus 3'->5' exoribonuclease that is critically involved in coronavirus RNA synthesis.

Authors:  Ekaterina Minskaia; Tobias Hertzig; Alexander E Gorbalenya; Valérie Campanacci; Christian Cambillau; Bruno Canard; John Ziebuhr
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-20       Impact factor: 11.205

3.  Evolutionary origins of the SARS-CoV-2 sarbecovirus lineage responsible for the COVID-19 pandemic.

Authors:  Maciej F Boni; Philippe Lemey; Xiaowei Jiang; Tommy Tsan-Yuk Lam; Blair W Perry; Todd A Castoe; Andrew Rambaut; David L Robertson
Journal:  Nat Microbiol       Date:  2020-07-28       Impact factor: 17.745

4.  A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2.

Authors:  Xiangyang Chi; Renhong Yan; Jun Zhang; Guanying Zhang; Yuanyuan Zhang; Meng Hao; Zhe Zhang; Pengfei Fan; Yunzhu Dong; Yilong Yang; Zhengshan Chen; Yingying Guo; Jinlong Zhang; Yaning Li; Xiaohong Song; Yi Chen; Lu Xia; Ling Fu; Lihua Hou; Junjie Xu; Changming Yu; Jianmin Li; Qiang Zhou; Wei Chen
Journal:  Science       Date:  2020-06-22       Impact factor: 47.728

5.  Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants.

Authors:  Yiska Weisblum; Fabian Schmidt; Fengwen Zhang; Justin DaSilva; Daniel Poston; Julio Cc Lorenzi; Frauke Muecksch; Magdalena Rutkowska; Hans-Heinrich Hoffmann; Eleftherios Michailidis; Christian Gaebler; Marianna Agudelo; Alice Cho; Zijun Wang; Anna Gazumyan; Melissa Cipolla; Larry Luchsinger; Christopher D Hillyer; Marina Caskey; Davide F Robbiani; Charles M Rice; Michel C Nussenzweig; Theodora Hatziioannou; Paul D Bieniasz
Journal:  Elife       Date:  2020-10-28       Impact factor: 8.140

6.  Correlates of protection against SARS-CoV-2 in rhesus macaques.

Authors:  Katherine McMahan; Jingyou Yu; Noe B Mercado; Carolin Loos; Lisa H Tostanoski; Abishek Chandrashekar; Jinyan Liu; Lauren Peter; Caroline Atyeo; Alex Zhu; Esther A Bondzie; Gabriel Dagotto; Makda S Gebre; Catherine Jacob-Dolan; Zhenfeng Li; Felix Nampanya; Shivani Patel; Laurent Pessaint; Alex Van Ry; Kelvin Blade; Jake Yalley-Ogunro; Mehtap Cabus; Renita Brown; Anthony Cook; Elyse Teow; Hanne Andersen; Mark G Lewis; Douglas A Lauffenburger; Galit Alter; Dan H Barouch
Journal:  Nature       Date:  2020-12-04       Impact factor: 49.962

7.  Case Study: Prolonged Infectious SARS-CoV-2 Shedding from an Asymptomatic Immunocompromised Individual with Cancer.

Authors:  Victoria A Avanzato; M Jeremiah Matson; Stephanie N Seifert; Rhys Pryce; Brandi N Williamson; Sarah L Anzick; Kent Barbian; Seth D Judson; Elizabeth R Fischer; Craig Martens; Thomas A Bowden; Emmie de Wit; Francis X Riedo; Vincent J Munster
Journal:  Cell       Date:  2020-11-04       Impact factor: 41.582

8.  High-Density Amplicon Sequencing Identifies Community Spread and Ongoing Evolution of SARS-CoV-2 in the Southern United States.

Authors:  Ryan P McNamara; Carolina Caro-Vegas; Justin T Landis; Razia Moorad; Linda J Pluta; Anthony B Eason; Cecilia Thompson; Aubrey Bailey; Femi Cleola S Villamor; Philip T Lange; Jason P Wong; Tischan Seltzer; Jedediah Seltzer; Yijun Zhou; Wolfgang Vahrson; Angelica Juarez; James O Meyo; Tiphaine Calabre; Grant Broussard; Ricardo Rivera-Soto; Danielle L Chappell; Ralph S Baric; Blossom Damania; Melissa B Miller; Dirk P Dittmer
Journal:  Cell Rep       Date:  2020-10-20       Impact factor: 9.423

9.  Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus.

Authors:  Bette Korber; Will M Fischer; Sandrasegaram Gnanakaran; Hyejin Yoon; James Theiler; Werner Abfalterer; Nick Hengartner; Elena E Giorgi; Tanmoy Bhattacharya; Brian Foley; Kathryn M Hastie; Matthew D Parker; David G Partridge; Cariad M Evans; Timothy M Freeman; Thushan I de Silva; Charlene McDanal; Lautaro G Perez; Haili Tang; Alex Moon-Walker; Sean P Whelan; Celia C LaBranche; Erica O Saphire; David C Montefiori
Journal:  Cell       Date:  2020-07-03       Impact factor: 66.850

View more
  201 in total

1.  Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies.

Authors:  Delphine Planas; Timothée Bruel; Ludivine Grzelak; Florence Guivel-Benhassine; Isabelle Staropoli; Françoise Porrot; Cyril Planchais; Julian Buchrieser; Maaran Michael Rajah; Elodie Bishop; Mélanie Albert; Flora Donati; Matthieu Prot; Sylvie Behillil; Vincent Enouf; Marianne Maquart; Mounira Smati-Lafarge; Emmanuelle Varon; Frédérique Schortgen; Layla Yahyaoui; Maria Gonzalez; Jérôme De Sèze; Hélène Péré; David Veyer; Aymeric Sève; Etienne Simon-Lorière; Samira Fafi-Kremer; Karl Stefic; Hugo Mouquet; Laurent Hocqueloux; Sylvie van der Werf; Thierry Prazuck; Olivier Schwartz
Journal:  Nat Med       Date:  2021-03-26       Impact factor: 53.440

2.  Dominance of Alpha and Iota variants in SARS-CoV-2 vaccine breakthrough infections in New York City.

Authors:  Ralf Duerr; Dacia Dimartino; Christian Marier; Paul Zappile; Guiqing Wang; Jennifer Lighter; Brian Elbel; Andrea B Troxel; Adriana Heguy
Journal:  J Clin Invest       Date:  2021-09-15       Impact factor: 14.808

3.  Laboratory Action Plan for Emerging SARS-CoV-2 Variants.

Authors:  Laura Filkins; Jeffrey A SoRelle; John Schoggins; Jason Y Park
Journal:  Clin Chem       Date:  2021-04-29       Impact factor: 8.327

4.  Longitudinal Analysis and Comparison of Six Serological Assays up to Eight Months Post-COVID-19 Diagnosis.

Authors:  Aurélien Aubry; Baptiste Demey; Catherine François; Gilles Duverlie; Sandrine Castelain; François Helle; Etienne Brochot
Journal:  J Clin Med       Date:  2021-04-21       Impact factor: 4.241

Review 5.  HIV-1 and SARS-CoV-2: Patterns in the evolution of two pandemic pathogens.

Authors:  Will Fischer; Elena E Giorgi; Srirupa Chakraborty; Kien Nguyen; Tanmoy Bhattacharya; James Theiler; Pablo A Goloboff; Hyejin Yoon; Werner Abfalterer; Brian T Foley; Houriiyah Tegally; James Emmanuel San; Tulio de Oliveira; Sandrasegaram Gnanakaran; Bette Korber
Journal:  Cell Host Microbe       Date:  2021-06-03       Impact factor: 31.316

6.  Improving the Outcomes of Immunocompromised Patients With Coronavirus Disease 2019.

Authors:  Ghady Haidar; John W Mellors
Journal:  Clin Infect Dis       Date:  2021-09-15       Impact factor: 9.079

7.  SARS-CoV-2 within-host diversity and transmission.

Authors:  Katrina A Lythgoe; Matthew Hall; Luca Ferretti; Mariateresa de Cesare; George MacIntyre-Cockett; Amy Trebes; Monique Andersson; Newton Otecko; Emma L Wise; Nathan Moore; Jessica Lynch; Stephen Kidd; Nicholas Cortes; Matilde Mori; Rebecca Williams; Gabrielle Vernet; Anita Justice; Angie Green; Samuel M Nicholls; M Azim Ansari; Lucie Abeler-Dörner; Catrin E Moore; Timothy E A Peto; David W Eyre; Robert Shaw; Peter Simmonds; David Buck; John A Todd; Thomas R Connor; Shirin Ashraf; Ana da Silva Filipe; James Shepherd; Emma C Thomson; David Bonsall; Christophe Fraser; Tanya Golubchik
Journal:  Science       Date:  2021-03-09       Impact factor: 47.728

Review 8.  SARS-CoV-2 variants, spike mutations and immune escape.

Authors:  William T Harvey; Alessandro M Carabelli; Ben Jackson; Ravindra K Gupta; Emma C Thomson; Ewan M Harrison; Catherine Ludden; Richard Reeve; Andrew Rambaut; Sharon J Peacock; David L Robertson
Journal:  Nat Rev Microbiol       Date:  2021-06-01       Impact factor: 78.297

9.  Prediction and Evolution of the Molecular Fitness of SARS-CoV-2 Variants: Introducing SpikePro.

Authors:  Fabrizio Pucci; Marianne Rooman
Journal:  Viruses       Date:  2021-05-18       Impact factor: 5.048

10.  Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7.

Authors:  Bo Meng; Steven A Kemp; Guido Papa; Rawlings Datir; Isabella A T M Ferreira; Sara Marelli; William T Harvey; Spyros Lytras; Ahmed Mohamed; Giulia Gallo; Nazia Thakur; Dami A Collier; Petra Mlcochova; Lidia M Duncan; Alessandro M Carabelli; Julia C Kenyon; Andrew M Lever; Anna De Marco; Christian Saliba; Katja Culap; Elisabetta Cameroni; Nicholas J Matheson; Luca Piccoli; Davide Corti; Leo C James; David L Robertson; Dalan Bailey; Ravindra K Gupta
Journal:  Cell Rep       Date:  2021-06-08       Impact factor: 9.995

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.